[1]
K. Gordon, “Certolizumab Pegol for Treatment of Plaque Psoriasis: Pooled Three-Year Efficacy Outcomes from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)”, J of Skin, vol. 4, no. 5, p. s44, Sep. 2020.